TAVR Imaging and Troubleshooting Presentation II (EP Video)
Dr. Arvind Kapila discusses part 2 of his presentation series on TAVR imaging and troubleshooting (55:37 minutes).
World's Largest Resource for Cardiovascular Perfusion
Dr. Arvind Kapila discusses part 2 of his presentation series on TAVR imaging and troubleshooting (55:37 minutes).
The available data demonstrate efficacy for all 3 antifibrinolytic drugs. Therefore, the agent with the most favorable safety profile should be used. As sufficient data are lacking, large comparative trials are warranted to assess the relative safety and appropriate dosing regimens in pediatrics.
Heparin resistance (HR) is occasionally encountered in cardiac surgery. The objective of this study is to identify possible factors predisposing patients to heparin resistance.